Trending Now
Menlo Therapeutics Inc. (NASDAQ:MNLO) Report Positive Data From Second Phase FCD105...
Menlo Therapeutics Inc. (NASDAQ:MNLO) has announced positive data from its second phase clinical study evaluating the initial efficacy and safety of FCD105. FCD105 is...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Clinches $450 Million Deal From The US...
The Trump administration awarded a $450 million contract under ‘Operation Warp Speed’ to Regeneron Pharmaceuticals Inc (NASDAQ:REGN)(RPC) to develop and quickly distribute the antibody...
MAKE IT MODERN
LATEST REVIEWS
Aldeyra Therapeutics Inc (NASDAQ:ALDX) Reports Topline Results From Phase 3 Clinical...
Aldeyra Therapeutics Inc (NASDAQ:ALDX) achieved positive results from Phase 3 clinical studies of reproxalap to treat patients with conjunctivitis.
The company accomplished statistical significance for...
MAKE IT MODERN
PERFORMANCE TRAINING
Leap Therapeutics Inc. (NASDAQ:LPTX) Receives Orphan Drug Designation For DKN-01 In Gastroesophageal Cancer
Leap Therapeutics Inc. (NASDAQ:LPTX) has announced that it has received Orphan Drug Designation from The FDA for DKN-01 in the treatment of gastroesophageal and...
Preclinical studies of a COVID-19 vaccine by Altimmune Inc (NASDAQ:ALT) at UAB Shows Potent...
There are hundreds of preclinical studies of a COVID-19 vaccine currently under development. Those in the advanced stages include AdCOVID from Altimmune Inc (NASDAQ:ALT)....
The Big Picture for Virus Testing Stocks (FLGT, ALST, CODX)
The good news is that the end of the pandemic is in sight. The bad news is that it may never really...
Celsion Corporation (NASDAQ: CLSN) Published Data From Phase 1b OVATION 1 GEN-1 Study In...
Celsion Corporation (NASDAQ: CLSN) has published Phase 1b OVATION 1 study data of GEN-1 combination with neoadjuvant chemotherapy in treating advanced ovarian...
Watch RXMD Shares as the COVID-19 Telehealth Drumbeat Picks Up Steam
Progressive Care Inc. (OTCMKTS:RXMD) shares have been bouncing around in a range over the past 6 months. Right now, the stock is...
MAKE IT MODERN
